On the initiative of the European Parliament’s Committee on Petitions (PETI), MEPs addressed the issue of transparency in the EU’s procurement and distribution strategy for Covid-19 vaccines in plenary session on Thursday 16 September.
“The fact that the Commission and Member States have legally restricted the publication of details of vaccine purchase contracts with pharmaceutical companies is problematic. This has happened despite the fact that the EU and Member States have publicly...